Tobacco and alcohol as risk factors for pancreatic cancer
- PMID: 29195672
- PMCID: PMC5747325
- DOI: 10.1016/j.bpg.2017.09.001
Tobacco and alcohol as risk factors for pancreatic cancer
Abstract
Pancreatic cancer is projected to become the leading cause of cancer deaths by 2050. The risk for pancreatic cancer may be reduced by up to 27% by modifying lifestyle risk factors, most notably tobacco smoking. Based on analysis of more than 2 million unselected individuals from general population, this article quantified the risk of pancreatic cancer in relation to lifelong tobacco smoking and alcohol consumption status, both alone and in combination. It also provided a state-of-the-art review of animal studies on the effect of tobacco smoke and alcohol on genetically engineered mouse models of pancreatic precursor lesions, as well as the role of immune microenvironment in pancreatic carcinogenesis activated by tobacco and alcohol.
Keywords: Alcohol; Genetically engineered mouse models; Pancreatic cancer; Population risk; Tobacco.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Research reported in this publication was supported by National Cancer Institute and National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award numbers U01DK108323 and U01DK108314. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Figures
Similar articles
-
Tobacco smoking, alcohol consumption and pancreatic cancer risk: a case-control study in Italy.Eur J Cancer. 2010 Jan;46(2):370-6. doi: 10.1016/j.ejca.2009.09.002. Epub 2009 Sep 24. Eur J Cancer. 2010. PMID: 19782561
-
Opium use, cigarette smoking, and alcohol consumption in relation to pancreatic cancer.Medicine (Baltimore). 2016 Jul;95(28):e3922. doi: 10.1097/MD.0000000000003922. Medicine (Baltimore). 2016. PMID: 27428185 Free PMC article.
-
Alcohol, tobacco and coffee consumption and the risk of pancreatic cancer: results from the Canadian Enhanced Surveillance System case-control project. Canadian Cancer Registries Epidemiology Research Group.Eur J Cancer Prev. 2000 Feb;9(1):49-58. doi: 10.1097/00008469-200002000-00007. Eur J Cancer Prev. 2000. PMID: 10777010
-
Modifiable and Non-Modifiable Risk Factors for the Development of Non-Hereditary Pancreatic Cancer.Medicina (Kaunas). 2022 Jul 22;58(8):978. doi: 10.3390/medicina58080978. Medicina (Kaunas). 2022. PMID: 35893093 Free PMC article. Review.
-
4. Chronic pancreatitis and pancreatic cancer, lifestyle-related diseases.Intern Med. 2007;46(2):109-13. doi: 10.2169/internalmedicine.46.1787. Epub 2007 Jan 15. Intern Med. 2007. PMID: 17220612 Review.
Cited by
-
Genomic Landscape of Pancreatic Adenocarcinoma in Younger versus Older Patients: Does Age Matter?Clin Cancer Res. 2019 Apr 1;25(7):2185-2193. doi: 10.1158/1078-0432.CCR-18-3042. Epub 2019 Jan 7. Clin Cancer Res. 2019. PMID: 30617137 Free PMC article.
-
Advances in Early Detection of Pancreatic Cancer.Diagnostics (Basel). 2019 Feb 5;9(1):18. doi: 10.3390/diagnostics9010018. Diagnostics (Basel). 2019. PMID: 30764550 Free PMC article. Review.
-
The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy.Front Oncol. 2021 Jul 15;11:688377. doi: 10.3389/fonc.2021.688377. eCollection 2021. Front Oncol. 2021. PMID: 34336673 Free PMC article. Review.
-
Opioid use as a potential risk factor for pancreatic cancer in the United States: An analysis of state and national level databases.PLoS One. 2021 Jan 6;16(1):e0244285. doi: 10.1371/journal.pone.0244285. eCollection 2021. PLoS One. 2021. PMID: 33406096 Free PMC article.
-
Risk of Developing Pancreatic Cancer in Patients with Chronic Pancreatitis.J Clin Med. 2020 Nov 19;9(11):3720. doi: 10.3390/jcm9113720. J Clin Med. 2020. PMID: 33228173 Free PMC article.
References
-
- American Cancer Society. Cancer Facts & Figures 2017. Atlanta, GA: American Cancer Society; 2017.
-
- Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403. - PubMed
-
- Global Burden of Disease Cancer C. Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2017;3:524–48. - PMC - PubMed
-
- Xiao AY, Tan ML, Wu LM, Asrani VM, Windsor JA, Yadav D, et al. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol. 2016;1:45–55. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical